Stroke/Brain Attack
14
3
4
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
7.1%
1 terminated out of 14 trials
75.0%
-11.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (14)
Expanded Access Multi-Patient Experimental Treatment Involving Allogeneic Human Mesenchymal Stem Cells (hMSCs) in Subjects With Acute Ischemic Stroke (EXPAND)
Efficacy of a Telehealth Delivered Group Lifestyle Balance for People Post Stroke (tGLB-CVA)
Accelerated rTMS vs. Sham for Stroke Apathy
Functional Efficiency of Self-sufficiency Test
Accelerated rTMS for Post-Stroke Apathy
Imaging Post-Stroke Recovery: Using MEG to Evaluate Cognition
Augmented Reality for Stroke Rehabilitation
Manually Controlled Infusion Vs Target Controlled Infusion for StrokeThrombectomy
Music Therapy After Stroke (Subacute Phase)
Physiological and Functional Effects of Percutaneous Neuromodulation vs Transcutaneous Neuromodulation
BCI Driving FES and Hand Orthosis for Upper Limb Rehabilitation in Chronic Stroke
Quantitative EEG Changes Following Repetitive Transcranial Magnetic Stimulation in Patients With Post Stroke (EEG-rTMS)
The Tele-Taking Charge After Stroke Randomized Controlled Feasibility Trial
Tendon Vibrations Effect on Upper Limb Motor Recovery After Recent Stroke